RGTI Q2 Secures Funding Amid Weak Sales: Time to Buy, Hold or Sell?

Rigetti Computing (RGTI) reported Q2 2025 revenue of $1.8 million, down from $3.1 million year-over-year, with gross margins narrowing to 31%, attributed partly to lower-margin government contracts. Despite this short-term revenue decline and a projected 19.7% revenue decrease for 2025, the company significantly bolstered its financial position with a $350 million equity offering, ending the quarter with $571.6 million in cash and no debt, providing substantial flexibility for R&D. Operationally, Rigetti introduced Cepheus-1-36Q, its largest multichip quantum computer to date with reduced error rates, and aims for a 100-plus qubit system by year-end, signaling continued progress in superconducting qubit technology. While the stock has outperformed some quantum peers year-to-date, its valuation appears elevated, and future success hinges on converting its technological advancements and strong cash position into broader commercial traction beyond its current reliance on government funding.

Analysis

Rigetti Computing's second-quarter 2025 results present a dichotomy between near-term financial strain and long-term strategic progress. Revenue declined significantly to $1.8 million from $3.1 million year-over-year, with gross margins contracting to 31% from 64%, primarily due to a reliance on lower-margin government contracts and the expiration of the National Quantum Initiative, which awaits reauthorization. Despite a projected 19.7% revenue decline for the full year, the company has substantially de-risked its financial position by raising $350 million, ending the quarter with a robust $571.6 million in cash and no debt. This provides a considerable runway to fund its aggressive R&D roadmap. Technologically, Rigetti demonstrated tangible progress with the introduction of Cepheus-1-36Q, its largest multichip quantum computer, which achieved a two-fold reduction in error rates. Management's confidence in delivering a 100-plus qubit system with 99.5% gate fidelity by year-end underscores its momentum in superconducting qubit architecture. However, the stock's valuation appears stretched, with a price-to-book ratio of 8.74x exceeding the industry average of 7.08x, and its 9.1% year-to-date gain lags both the sector's top performer, QBTS (+102.5%), and the broader industry.

Key Decisions for Investors

• Given the company's pre-commercial stage, significant operating losses, and revenue volatility, RGTI is most suitable for investors with a high-risk tolerance and a long-term investment horizon focused on disruptive technology.
• Investors should closely monitor two key catalysts: the legislative progress on the reauthorization of the National Quantum Initiative, which directly impacts near-term revenue, and the company's ability to meet its year-end target for a 100-plus qubit system.
• The strong balance sheet, with $571.6 million in cash and no debt, provides a significant operational buffer, potentially justifying a hold position through near-term headwinds for existing investors.
• Considering the elevated price-to-book ratio of 8.74x, prospective investors should be cautious of the current valuation and might look for a more favorable entry point, particularly as the company projects a revenue decline for the full year.